Related Experiment Video
Updated: May 20, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Intraindividual differences between two simultaneous glucose measurement systems in type 2 diabetic patients
Lars Stechemesser1, Agnes Hammerschmied, Brigitta Gappmayer
1Department of Internal Medicine I, Paracelsus Medical University Clinic Salzburg, Müllner Hauptstrasse 48, 5020, Salzburg, Austria. l.stechemesser@salk.at
Wiener Klinische Wochenschrift
|July 7, 2012
Summary
Continuous glucose monitoring (CGM) systems like GlucoDay and MiniMed show differences in accuracy for type 2 diabetes patients. GlucoDay tended to show higher glucose levels and greater fluctuations compared to MiniMed.
Area of Science:
- Endocrinology
- Medical Devices
- Diabetes Technology
Background:
- Continuous glucose measurement (CGM) systems are vital for managing diabetes therapy.
- Different technical designs of CGM devices can lead to varying limitations in practical application.
Purpose of the Study:
- To compare the accuracy of two distinct CGM devices, GlucoDay and MiniMed, in a head-to-head evaluation.
- To identify individual performance characteristics of these CGM systems in daily routine use.
Main Methods:
- A study involving 24 patients with type 2 diabetes mellitus.
- Simultaneous 48-hour wear of GlucoDay and MiniMed CGM systems.
- Analysis of mean differences and confidence intervals for simultaneous glucose measurements.
Main Results:
- A trend for higher glucose readings was observed with the GlucoDay system compared to MiniMed.
- Differences in glucose measurements varied depending on the time of day.
- The GlucoDay system exhibited greater fluctuation between consecutive measurements.
Conclusions:
- Discrepancies between GlucoDay and MiniMed CGM systems in type 2 diabetes patients warrant consideration.
- These differences are important for detecting nocturnal hypoglycemia and interpreting trends for treatment adjustments.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.